データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
データなし
Lacklustre Performance Is Driving LakeShore Biopharma Co., Ltd's (NASDAQ:LSB) 66% Price Drop
LakeShore Biopharma Regains Compliance With Nasdaq Minimum Bid Price Requirement
LakeShore Biopharma Receives Phase III Trial Approval In China For Simplified Four-Dose YSJA Rabies Vaccine Regimen; Aims To Enhance Patient Adherence And Reduce Costs While Maintaining Immunogenicity
LakeShore Biopharma Shares Higher on Unchanged FY Guidance
LakeShore Biopharma Sees Prelim. 1H Revenue RMB350M-RMB380M, Representing 28-39% Growth
Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
データなし
データなし